Bala Deshpande, India head of US venture capital fund NEA, is setting up an independent investment firm along with her three colleagues, said three people aware of the development.
NEA (New Enterprise Associates) is a California-based global venture capital firm.
NIIMBL is pleased to announce the Quick Start Project (QSP) call. The QSP call solicits proposals for open topic, industry-wide projects focused on the NIIMBL mission of advancing biopharmaceutical manufacturing. Proposal Submission Process Details regarding the proposal submission process and required documents can be found in Section 6 of the RFP document.
After several weeks of talks, Discovery Communications Inc. has reached a deal to acquire the owner of HGTV and Travel Channel.
The Silver Spring-based company announced Monday morning that it would acquire Scripps Networks Interactive Inc. in a cash-and-stock deal valued at $14.6 billion. The transaction is valued at $90 per share — roughly a 4 percent premium on Scripps’ Friday closing price of $86.91 and a 34 percent premium on its share price since Scripps ownership began discussing a sale earlier this month.
With more than 15 years as a nonprofit professional, Amanda joins the Fort Detrick Alliance with extensive experience in communications, marketing, fundraising, event planning, public relations, and management. She replaces Eileen Mitchell, who served as Executive Director since December 2015 In her career, Amanda served as the Assistant Director at the Historical Society of Frederick County; Marketing Manager at the National Shrine of Saint Elizabeth Ann Seton; Marketing director of Black Rock Center for the Arts; and Public Relations Specialist at the University System of Maryland at Hagerstown. Amanda has been instrumental in tourism marketing in the region and served for four years on the Tourism Council of Frederick County’s marketing and group sales committees. As a writer and journalist, Amanda published articles in Frederick Magazine, Find It Frederick magazine, Eastern Home and Travel, the Baltimore Sun, and other regional publications. Amanda may be reached at 301-788-9896 or email director@fortdetrickalliance.org Thank you for your continued support of Fort Detrick and the Alliance. We hope to see you at one of our events. If you are interested in becoming a member of the Alliance, please feel free to contact me at director@fortdetrickalliance.org.
Amanda Johnston Executive Director
BHI Q&A with 3i Diagnostics, Inc. President & CEO, Jim Janicki & Chief Technology Officer, Rajesh Krishnamurthy
Company: 3i Diagnostics, Inc. “3iDx” www.3iDx.com
Location: Germantown Innovation Center/Launch Labs
Founded: 2013
Overview: 3iDx is an early stage company developing a new technology platform that is able to isolate and analyze microbes directly from samples for the purpose of identifying antimicrobial resistant strains in less than an hour without having to wait for up to a week for blood culture results. Their ultimate aim is to create a 15-minute test that runs in a battery powered handheld device.
AstraZeneca and MedImmune, have today announced that the US Food and Drug Administration (FDA) has granted breakthrough therapy designation for Imfinzi (durvalumab) for the treatment of patients with locally-advanced, unresectable non-small cell lung cancer (NSCLC) whose disease has not progressed following platinum-based chemoradiation therapy.
GlaxoSmithKline (GSK) is axing 130 ‘non-core’ brands and overhauling its prescription drugs business to focus on products that deliver stronger returns.
It is also stepping up a cost reduction program that has already bitten into media and marketing budgets across the consumer healthcare portfolio.
AstraZeneca and Merck & Co. announced on July 27, 2017 that they have entered a global strategic oncology collaboration to co-develop and co-commercialize AstraZeneca’s Lynparza (olaparib) for multiple cancer types. Lynparza is an oral poly ADP ribose polymerase (PARP) inhibitor for treating BRCA-mutated ovarian cancer in multiple lines of treatment. It was approved by FDA in December 2014 and generated 2016 sales of $218 million.
The Inova Personalized Health Accelerator (IPHA) is preparing to accept applications from early-stage startups focused on predicting, preventing and treating disease. Falls Church-based Inova Health System announced plans for the accelerator last December when it also launched Inova Strategic Investments, a venture-capital program. Both projects are housed at the new Inova Center for Personalized Health, a 117-acre campus in Fairfax County.
The road to launching a life science start-up can be a long and difficult one, with founders often struggling to secure funding and manage the logistics of setting up a business. In a move to encourage innovation and help start-ups hit the ground running, there are an increasing choice of accelerator and support programs becoming available.
We spoke to Giovanni Rizzo, PhD MBA Chief of Innovation Division, Z-Cube S.r.l. to learn more about such programs and the difference they can make to innovation, as well as share some tips for academics beginning a start-up venture.
